Selected research
Industry Research
NAD+ IV Therapy Industry Research Report 2026
Market perspective
The global NAD+ IV Therapy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the NAD+ IV Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the NAD+ IV Therapy market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the NAD+ IV Therapy market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of NAD+ IV Therapy include Toronto Functional Medicine Centre, Thedripclub, The Wellness Lab, Seaside Skin Care, Rocky Mountain Ivmedics, Reset IV, Premiumhealth, Nadclinic and Mobileivmedics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global NAD+ IV Therapy market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to NAD+ IV Therapy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
NAD+ IV Therapy Market by Company
Toronto Functional Medicine Centre
Thedripclub
The Wellness Lab
Seaside Skin Care
Rocky Mountain Ivmedics
Reset IV
Premiumhealth
Nadclinic
Mobileivmedics
LIVV Natural
IV Boost UK
Hydrate IV Bar
Effect Doctors
Conciergemdla
BioReset Medical
Azivmedics
NAD+ IV Therapy Segment by Type
NAD+ Mixed Vitamin Injections
Pure NAD+ Injection
NAD+ IV Therapy Segment by Application
Clinic
Hospital
Residential
NAD+ IV Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ IV Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NAD+ IV Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ IV Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of NAD+ IV Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NAD+ Mixed Vitamin Injections
- Pure NAD+ Injection
Applications
- Clinic
- Hospital
- Residential
Companies covered
- Toronto Functional Medicine Centre
- Thedripclub
- The Wellness Lab
- Seaside Skin Care
- Rocky Mountain Ivmedics
- Reset IV
- Premiumhealth
- Nadclinic
- Mobileivmedics
- LIVV Natural
- IV Boost UK
- Hydrate IV Bar
- Effect Doctors
- Conciergemdla
- BioReset Medical
- Azivmedics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 NAD+ IV Therapy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 NAD+ Mixed Vitamin Injections
- 2.2.3 Pure NAD+ Injection
- 2.3 NAD+ IV Therapy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinic
- 2.3.3 Hospital
- 2.3.4 Residential
- 2.4 Assumptions and Limitations
3 NAD+ IV Therapy Breakdown Data by Type
- 3.1 Global NAD+ IV Therapy Historic Market Size by Type (2021-2026)
- 3.2 Global NAD+ IV Therapy Forecasted Market Size by Type (2027-2032)
4 NAD+ IV Therapy Breakdown Data by Application
- 4.1 Global NAD+ IV Therapy Historic Market Size by Application (2021-2026)
- 4.2 Global NAD+ IV Therapy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global NAD+ IV Therapy Market Perspective (2021-2032)
- 5.2 Global NAD+ IV Therapy Growth Trends by Region
- 5.2.1 Global NAD+ IV Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 NAD+ IV Therapy Historic Market Size by Region (2021-2026)
- 5.2.3 NAD+ IV Therapy Forecasted Market Size by Region (2027-2032)
- 5.3 NAD+ IV Therapy Market Dynamics
- 5.3.1 NAD+ IV Therapy Industry Trends
- 5.3.2 NAD+ IV Therapy Market Drivers
- 5.3.3 NAD+ IV Therapy Market Challenges
- 5.3.4 NAD+ IV Therapy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top NAD+ IV Therapy Players by Revenue
- 6.1.1 Global Top NAD+ IV Therapy Players by Revenue (2021-2026)
- 6.1.2 Global NAD+ IV Therapy Revenue Market Share by Players (2021-2026)
- 6.2 Global NAD+ IV Therapy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of NAD+ IV Therapy Head Office and Area Served
- 6.4 Global NAD+ IV Therapy Players, Product Type & Application
- 6.5 Global NAD+ IV Therapy Manufacturers Established Date
- 6.6 Global NAD+ IV Therapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America NAD+ IV Therapy Market Size (2021-2032)
- 7.2 North America NAD+ IV Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America NAD+ IV Therapy Market Size by Country (2021-2026)
- 7.4 North America NAD+ IV Therapy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe NAD+ IV Therapy Market Size (2021-2032)
- 8.2 Europe NAD+ IV Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe NAD+ IV Therapy Market Size by Country (2021-2026)
- 8.4 Europe NAD+ IV Therapy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific NAD+ IV Therapy Market Size (2021-2032)
- 9.2 Asia-Pacific NAD+ IV Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific NAD+ IV Therapy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific NAD+ IV Therapy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America NAD+ IV Therapy Market Size (2021-2032)
- 10.2 South America NAD+ IV Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America NAD+ IV Therapy Market Size by Country (2021-2026)
- 10.4 South America NAD+ IV Therapy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa NAD+ IV Therapy Market Size (2021-2032)
- 11.2 Middle East & Africa NAD+ IV Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa NAD+ IV Therapy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa NAD+ IV Therapy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Toronto Functional Medicine Centre
- 12.1.1 Toronto Functional Medicine Centre Company Information
- 12.1.2 Toronto Functional Medicine Centre Business Overview
- 12.1.3 Toronto Functional Medicine Centre Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.1.4 Toronto Functional Medicine Centre NAD+ IV Therapy Product Portfolio
- 12.1.5 Toronto Functional Medicine Centre Recent Developments
- 12.2 Thedripclub
- 12.2.1 Thedripclub Company Information
- 12.2.2 Thedripclub Business Overview
- 12.2.3 Thedripclub Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.2.4 Thedripclub NAD+ IV Therapy Product Portfolio
- 12.2.5 Thedripclub Recent Developments
- 12.3 The Wellness Lab
- 12.3.1 The Wellness Lab Company Information
- 12.3.2 The Wellness Lab Business Overview
- 12.3.3 The Wellness Lab Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.3.4 The Wellness Lab NAD+ IV Therapy Product Portfolio
- 12.3.5 The Wellness Lab Recent Developments
- 12.4 Seaside Skin Care
- 12.4.1 Seaside Skin Care Company Information
- 12.4.2 Seaside Skin Care Business Overview
- 12.4.3 Seaside Skin Care Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.4.4 Seaside Skin Care NAD+ IV Therapy Product Portfolio
- 12.4.5 Seaside Skin Care Recent Developments
- 12.5 Rocky Mountain Ivmedics
- 12.5.1 Rocky Mountain Ivmedics Company Information
- 12.5.2 Rocky Mountain Ivmedics Business Overview
- 12.5.3 Rocky Mountain Ivmedics Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.5.4 Rocky Mountain Ivmedics NAD+ IV Therapy Product Portfolio
- 12.5.5 Rocky Mountain Ivmedics Recent Developments
- 12.6 Reset IV
- 12.6.1 Reset IV Company Information
- 12.6.2 Reset IV Business Overview
- 12.6.3 Reset IV Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.6.4 Reset IV NAD+ IV Therapy Product Portfolio
- 12.6.5 Reset IV Recent Developments
- 12.7 Premiumhealth
- 12.7.1 Premiumhealth Company Information
- 12.7.2 Premiumhealth Business Overview
- 12.7.3 Premiumhealth Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.7.4 Premiumhealth NAD+ IV Therapy Product Portfolio
- 12.7.5 Premiumhealth Recent Developments
- 12.8 Nadclinic
- 12.8.1 Nadclinic Company Information
- 12.8.2 Nadclinic Business Overview
- 12.8.3 Nadclinic Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.8.4 Nadclinic NAD+ IV Therapy Product Portfolio
- 12.8.5 Nadclinic Recent Developments
- 12.9 Mobileivmedics
- 12.9.1 Mobileivmedics Company Information
- 12.9.2 Mobileivmedics Business Overview
- 12.9.3 Mobileivmedics Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.9.4 Mobileivmedics NAD+ IV Therapy Product Portfolio
- 12.9.5 Mobileivmedics Recent Developments
- 12.10 LIVV Natural
- 12.10.1 LIVV Natural Company Information
- 12.10.2 LIVV Natural Business Overview
- 12.10.3 LIVV Natural Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.10.4 LIVV Natural NAD+ IV Therapy Product Portfolio
- 12.10.5 LIVV Natural Recent Developments
- 12.11 IV Boost UK
- 12.11.1 IV Boost UK Company Information
- 12.11.2 IV Boost UK Business Overview
- 12.11.3 IV Boost UK Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.11.4 IV Boost UK NAD+ IV Therapy Product Portfolio
- 12.11.5 IV Boost UK Recent Developments
- 12.12 Hydrate IV Bar
- 12.12.1 Hydrate IV Bar Company Information
- 12.12.2 Hydrate IV Bar Business Overview
- 12.12.3 Hydrate IV Bar Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.12.4 Hydrate IV Bar NAD+ IV Therapy Product Portfolio
- 12.12.5 Hydrate IV Bar Recent Developments
- 12.13 Effect Doctors
- 12.13.1 Effect Doctors Company Information
- 12.13.2 Effect Doctors Business Overview
- 12.13.3 Effect Doctors Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.13.4 Effect Doctors NAD+ IV Therapy Product Portfolio
- 12.13.5 Effect Doctors Recent Developments
- 12.14 Conciergemdla
- 12.14.1 Conciergemdla Company Information
- 12.14.2 Conciergemdla Business Overview
- 12.14.3 Conciergemdla Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.14.4 Conciergemdla NAD+ IV Therapy Product Portfolio
- 12.14.5 Conciergemdla Recent Developments
- 12.15 BioReset Medical
- 12.15.1 BioReset Medical Company Information
- 12.15.2 BioReset Medical Business Overview
- 12.15.3 BioReset Medical Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.15.4 BioReset Medical NAD+ IV Therapy Product Portfolio
- 12.15.5 BioReset Medical Recent Developments
- 12.16 Azivmedics
- 12.16.1 Azivmedics Company Information
- 12.16.2 Azivmedics Business Overview
- 12.16.3 Azivmedics Revenue in NAD+ IV Therapy Business (2021-2026)
- 12.16.4 Azivmedics NAD+ IV Therapy Product Portfolio
- 12.16.5 Azivmedics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst